CTP - Solid

Cytidine 5'-triphosphate, Disodium salt trihydrate

Catálogo Nº Apresentação Preço (R$) Comprar
NUC-204S 1 g250,00 Adicionar ao Carrinho
NUC-204M 10 g2.050,00 Adicionar ao Carrinho
NUC-204L 100 g16.500,00 Adicionar ao Carrinho

For research use only!

Envio: shipped on blue ice

Condições de armazenamento: store at -20 °C
Short term exposure (up to 1 week cumulative) to ambient temperature possible.

Validade: 12 months after date of delivery

Fórmula molecular: C9H16N3O14P3 (free acid)

Peso molecular: 483.16 g/mol (free acid)

CAS#: 36051-68-0

Número CE: 252-849-3

Pureza: ≥ 95 % (HPLC)

Forma: lyophilised

Propriedades espectroscópicas: λmax 271 nm, ε 8.9 L mmol-1 cm-1 (Tris-HCl pH 7.0)

Formulários:
Physiological role in coronary artery disease[1]
Physiolocal role in lipid metabolism[2]
Physiological role in farnesol induced apoptosis[3]

Specific Ligands:

CTP synthase[4]

Phosphocholine cytidyltransferase alpha[2]

Ligand for purinergic receptors:
P2Y6[5]
P2X3[6]

Quality Control Specifications:
in vitro transcription (T7 RNA polymerase): visible RNA fragments after 5 min incubation, DNases, RNases, Nicking Activity: not detectable, Proteases: not detectable

Referências selecionadas:
[1] Lui et al. (2010) Evaluation of CT perfusion in setting of cerebral ischemia:patterns and pitfalls. American Journal of Neuroradiology 31:1552.
[2] Luoma (2010) Gene activation regresses artheriosclerosis, promotes health, and enhances longevity. Lipids in health and disease 9:67.
[3] Joo et al. (2010) Molecular mechanisms involved in farnesol-induced apotosis. Cancer letters 287:123.
[4] Cabeen et al. (2010) A metabolic assembly line in bacteria. Nature Cell Biology 12:731.
[5]Jayasekara et al. (2013) 4-Alkoxyimino-cytosine nucleotides: tethering approaches to molecular probes for the P2Y6 receptor. MedChemComm. 4 (8):1156.
[6]Garzia-Guzman et al. (1997) Molecular characterization and pharmacological properties of the human P2X3 purinoreceptor. Mol. Brain Res. 47 (1):59.
Spangler et al. (2011) Interaction of the diguanylate cyclase YdeH of Escherichia coli with 2', (3')-substituted purine and pyrimidine nucleotides. J. Pharmacol. Exp. Ther. 336 (1):234.